Terns Pharmaceuticals Inc (TERN)
5.44
+0.15
(+2.84%)
USD |
NASDAQ |
May 03, 16:00
5.435
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Investing (TTM): -37.99M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -37.99M |
| September 30, 2023 | -99.76M |
| June 30, 2023 | -78.69M |
| March 31, 2023 | -3.829M |
| December 31, 2022 | -22.27M |
| September 30, 2022 | -14.15M |
| June 30, 2022 | -8.464M |
| Date | Value |
|---|---|
| March 31, 2022 | -13.39M |
| December 31, 2021 | -119.70M |
| September 30, 2021 | -113.32M |
| June 30, 2021 | -117.77M |
| March 31, 2021 | -96.97M |
| December 31, 2020 | 6.693M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-119.70M
Minimum
Dec 2021
6.693M
Maximum
Dec 2020
-55.35M
Average
-37.99M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
| Viking Therapeutics Inc | -641.08M |
| Eli Lilly and Co | -7.642B |
| Pfizer Inc | -32.28B |
| Amgen Inc | -27.78B |
| Madrigal Pharmaceuticals Inc | -502.52M |